Cancer drug development and translational research are high priorities of special workshop.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D016503:Drug Delivery Systems; D015195:Drug Design; D004493:Education / Q000458:organization & administration*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D012106:Research / Q000639:trends*; D013678:Technology, Pharmaceutical
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor